Key result
Warfarin monitoring using prothrombin time is problematic due to marked variability in the responsiveness of different thromboplastins to the anticoagulant effects of the drug.
Highlights the variability in thromboplastin responsiveness and its impact on the interpretation of prothrombin time for warfarin monitoring.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Jack Hirsh (1992) conducted an editorial in Warfarin therapy monitoring. Warfarin was evaluated. Warfarin monitoring using prothrombin time is problematic due to marked variability in the responsiveness of different thromboplastins to the anticoagulant effects of the drug.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: